» Articles » PMID: 20961312

Lymphatic System: a Vital Link Between Metabolic Syndrome and Inflammation

Overview
Specialty Science
Date 2010 Oct 22
PMID 20961312
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Metabolic syndrome is defined by a cluster of different metabolic risk factors that include overall and central obesity, elevated fasting glucose levels, dyslipidemia, hypertension, and intimal atherogenesis. Metabolic syndrome leads to increased risk for the development of type 2 diabetes and cardiovascular disease (e.g., heart disease and stroke). The exacerbated progression of metabolic syndrome to cardiovascular disease has lead to intense study of the physiological ramifications of metabolic syndrome on the blood vasculature. These studies have particularly focused on the signaling and architectural alterations that manifest in hypertension and atherosclerosis. However, despite the overlap of metabolic syndrome pathology with lymphatic function, tangent effects on the lymphatic system have not been extensively documented. In this review, we discuss the current status of metabolic syndrome and provide evidence for, and the remaining challenges in studying, the connections among the lymphatic system, lipid transport, obesity, insulin resistance, and general inflammation.

Citing Articles

Multi-parameter tunable synthetic matrix for engineering lymphatic vessels.

Alderfer L, Saha S, Fan F, Wu J, Littlepage L, Hanjaya-Putra D Commun Biol. 2024; 7(1):1262.

PMID: 39367247 PMC: 11452684. DOI: 10.1038/s42003-024-06935-7.


Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may reduce the risk of developing cancer-related lymphedema following axillary lymph node dissection (ALND).

Brown S, Tadros A, Montagna G, Bell T, Crowley F, Gallagher E Front Pharmacol. 2024; 15:1457363.

PMID: 39318780 PMC: 11420520. DOI: 10.3389/fphar.2024.1457363.


A comparative evaluation of the efficacy of complete decongestive therapy in the treatment of unilateral breast cancer-related lymphedema with and without metabolic syndrome.

Pirincci C, Mete O, Yasa M, Dalyan M Support Care Cancer. 2024; 32(7):473.

PMID: 38949715 PMC: 11217042. DOI: 10.1007/s00520-024-08676-z.


Detection of Mast Cells in Human Superficial Fascia.

Fede C, Petrelli L, Pirri C, Tiengo C, De Caro R, Stecco C Int J Mol Sci. 2023; 24(14).

PMID: 37511360 PMC: 10380524. DOI: 10.3390/ijms241411599.


Metabolic syndrome score as an indicator in a predictive nomogram for lymph node metastasis in endometrial cancer.

Feng X, Li X, Yang X, Cheng Y, Dong Y, Wang J BMC Cancer. 2023; 23(1):622.

PMID: 37403054 PMC: 10318658. DOI: 10.1186/s12885-023-11053-4.


References
1.
Akopian V, Balashov N, Khanipov G . [Effect of calcitonin gene-related peptide on lymphatic vessels]. Zh Evol Biokhim Fiziol. 1999; 34(6):675-82. View

2.
Leak L . The structure of lymphatic capillaries in lymph formation. Fed Proc. 1976; 35(8):1863-71. View

3.
Maby-El Hajjami H, Petrova T . Developmental and pathological lymphangiogenesis: from models to human disease. Histochem Cell Biol. 2008; 130(6):1063-78. DOI: 10.1007/s00418-008-0525-5. View

4.
Karagiannides I, Torres D, Tseng Y, Bowe C, Carvalho E, Espinoza D . Substance P as a novel anti-obesity target. Gastroenterology. 2008; 134(3):747-55. PMC: 2359157. DOI: 10.1053/j.gastro.2007.12.032. View

5.
Hosaka K, Rayner S, von der Weid P, Zhao J, Imtiaz M, van Helden D . Calcitonin gene-related peptide activates different signaling pathways in mesenteric lymphatics of guinea pigs. Am J Physiol Heart Circ Physiol. 2005; 290(2):H813-22. DOI: 10.1152/ajpheart.00543.2005. View